跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 86 条关于
“axSpA”
全部
86
临床试验
53
药物
3
机构
0
资讯
30
去年
Certolizumab Pegol Reduces Inflammation in axSpA but Clinical Improvement Varies
去年
Bimekizumab Demonstrates Sustained Three-Year Efficacy in Psoriatic Arthritis and Axial Spondyloarthritis
去年
Filgotinib Meets Primary Endpoint in Phase 3 Trial for Axial Spondyloarthritis
10个月前
FDA Grants Breakthrough Device Designation to Augurex's SPINEstat Test for Axial Spondyloarthritis Diagnosis
去年
Bimekizumab Shows Sustained Efficacy in Psoriatic Arthritis and Axial Spondyloarthritis in New Two-Year Data
去年
TNF Inhibitors Reduce Fracture Risk in Axial Spondyloarthritis Patients
去年
Bimzelx Shows Sustained Efficacy and Safety in Psoriatic Arthritis and Axial Spondyloarthritis
去年
FDA Approves Bimekizumab (Bimzelx) for Psoriatic Arthritis and Axial Spondyloarthritis
去年
Bimekizumab Shows Sustained Efficacy in Psoriatic Arthritis at 2 Years
去年
Hillstar Bio Raises $67M Series A to Advance Precision Immunotherapy for Autoimmune Diseases
第 1 页,共 3 页
上一页
下一页